
The bank raised its estimate again as Chinese makers move from demonstrations into commercial deployments, with China already accounting for more than 80% of global humanoid deployments in 2025.
Morgan Stanley has again raised its forecast for China humanoid robot shipments in 2026 to 50,000 units, up from 28,000 earlier in the year and 14,000 at the start of 2026, as Chinese manufacturers move more quickly from exhibitions into commercial deployments. Sheng Zhong, an equity analyst at Morgan Stanley, said “commercial verification, policy support, and supply-chain feedback point to faster humanoid adoption in China.” The bank estimates China’s humanoid robot market will reach $2 billion in 2026 and grow to $15 billion by 2030, with annual shipments climbing to 446,000 units, counting only external sales and excluding robots built for prototypes, trials or internal testing. More than 16,000 humanoid robots were deployed globally in 2025, with China accounting for more than 80%, and AGIBOT, Unitree, UBTECH and Leju were the leading vendors. The gap with the U.S. remains wide in production scale: Omdia data cited by Fortune showed Agibot and Unitree each shipped more than 5,000 units last year, while Figure AI and Tesla each shipped only a few hundred or fewer. Unitree reported 2025 revenue of 1.7 billion yuan ($250 million) and profit of 278 million yuan ($41 million), while Unitree and Agibot are preparing IPOs that would value them at a combined $13 billion. In the U.S., Agility Robotics has said it plans to go public through a SPAC deal with Churchill Capital that values the company at $2.5 billion pre-money.